Semi-Markov model for evaluating the HIV patient treatment cost

Simple item page
dc.creatorMbogo, Rachel Waema
dc.creatorLuboobi, Livingstone S.
dc.creatorOdhiambo, John W.
dc.date07/07/2014
dc.dateMon, 7 Jul 2014
dc.dateMon, 7 Jul 2014 13:48:51
dc.dateMon, 7 Jul 2014 13:48:51
dc.date.accessioned2015-03-18T11:29:12Z
dc.date.available2015-03-18T11:29:12Z
dc.descriptionArticle
dc.description
dc.description.abstractThe aim of this study is to model the progression of HIV/AIDS disease and evaluate the cost of the anti-retroviral therapy for an HIV infected patient under ART follow-up using Non homogeneous semi-Markov processes. States of the Markov process are defined by the seriousness of the sickness based on the clinical scores. The five states considered are: Asymptomatic (CD$^{+}_{4}$ count > 500 cells/microliter); Symptomatic 1 (350 < CD$^{+}_{4}$ count ≤ 500 cells/microliter); Symptomatic 2 (200 < CD$^{+}_{4}$ count ≤ 350 cells/microliter); AIDS (CD$^{+}_{4}$ count ≤ 200 cells/microliter) and Death (Absorbing state). The first four states are named as good or alive states. The models formulated can be used to gain insights on the transition dynamics of the HIV patient given the follow-up time. The transition probability Model, when fitted with data will give insights on the conditional probability of a patient moving from one disease state to another, given the current state and the follow-up time. This model will also give the probability of survival for the HIV patient under treatment given the current state and follow-up time. The total Lifetime Treatment Cost model obtained, when applied to real data will give the cost of managing an HIV patient given the starting state, the treatment combination which incurs minimum cost and which treatment combination is most effective at each state. The treatment reward model also when applied to real data will give the state, which a patient should be maintained so that they remain healthy, noninfectious and productive to the society. Also the model will show the optimal/effective time to initiate treatment, which can be used to give advice on how to handle the HIV infecteds given their states.
dc.identifier.urihttp://hdl.handle.net/11071/3784
dc.languageeng
dc.rightsBy agreeing with and accepting this license, I (the author(s), copyright owner or nominated agent) agree to the conditions, as stated below, for deposit of the item (referred to as .the Work.) in the digital repository maintained by Strathmore University, or any other repository authorized for use by Strathmore University. Non-exclusive Rights Rights granted to the digital repository through this agreement are entirely non-exclusive. I understand that depositing the Work in the repository does not affect my rights to publish the Work elsewhere, either in present or future versions. I agree that Strathmore University may electronically store, copy or translate the Work to any approved medium or format for the purpose of future preservation and accessibility. Strathmore University is not under any obligation to reproduce or display the Work in the same formats or resolutions in which it was originally deposited. SU Digital Repository I understand that work deposited in the digital repository will be accessible to a wide variety of people and institutions, including automated agents and search engines via the World Wide Web. I understand that once the Work is deposited, metadata may be incorporated into public access catalogues. I agree as follows: 1.That I am the author or have the authority of the author/s to make this agreement and do hereby give Strathmore University the right to make the Work available in the way described above. 2.That I have exercised reasonable care to ensure that the Work is original, and to the best of my knowledge, does not breach any laws including those relating to defamation, libel and copyright. 3.That I have, in instances where the intellectual property of other authors or copyright holders is included in the Work, gained explicit permission for the inclusion of that material in the Work, and in the electronic form of the Work as accessed through the open access digital repository, or that I have identified that material for which adequate permission has not been obtained and which will be inaccessible via the digital repository. 4.That Strathmore University does not hold any obligation to take legal action on behalf of the Depositor, or other rights holders, in the event of a breach of intellectual property rights, or any other right, in the material deposited. 5.That if, as a result of my having knowingly or recklessly given a false statement at points 1, 2 or 3 above, the University suffers loss, I will make good that loss and indemnify Strathmore University for all action, suits, proceedings, claims, demands and costs occasioned by the University in consequence of my false statement.
dc.subjectHIV evolution
dc.subjectTherapeutic intervention
dc.subjectNon homogeneity
dc.subjectTreatment Cost
dc.subjectSemi-Markov model
dc.subjecttransition probabilities
dc.subjectreward model.
dc.titleSemi-Markov model for evaluating the HIV patient treatment cost
dc.typeArticle
Files
Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
Semi-Markov model for evaluating the HIV.pdf
Size:
265.35 KB
Format:
Adobe Portable Document Format
Description:
Article
Download
Collections
SIMs Scholarly Articles